TECH
NasdaqBIO-TECHNE Corp
Health Care, Life Sciences Tools & Services
$72.29
close 7 Aug 2026
+44.15%
52-week change
$11.31B
market cap
$43.20
$72.37
52-week range
Valuation
Market cap$11.31B
P/E (TTM / 5y avg)104.77x74.30x
Forward P/E (FY2026 / FY2027)37.68x35.37x
PEG (TTM / fwd)—5.78
P/S (TTM)9.34x
P/B5.43x
EV/EBITDA (TTM)44.70x
FCF yield (TTM)2.38%
Cash flow & dividend
FCF (TTM)$269.60M
FCF per share (TTM)$1.72
FCF margin (TTM)22.27%
Dividend yield (indicated / 5y avg)0.44%0.44%
Annualized dividend$0.3200
Payout ratio (EPS / FCF)45.47%18.48%
Growth & quality
Revenue YoY, latest Q-1.51%
Diluted EPS YoY, latest Q+128.57%
Operating margin (TTM)12.70%
Net margin (TTM)9.05%
ROE (latest FY)3.83%
Net debt / EBITDA (TTM)-0.04
Interest coverage (TTM)15.88
Price
-38.07%-9.17%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +10.55%10Y CAGR +10.43%
Diluted EPS
5Y CAGR -20.57%10Y CAGR -4.41%
FCF per share
5Y CAGR +10.55%10Y CAGR +7.21%
Operating cash flow
5Y CAGR +6.98%10Y CAGR +7.51%
Free cash flow
5Y CAGR +10.82%10Y CAGR +7.94%
Dividends per share
5Y CAGR +0.35%10Y CAGR -0%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR +0.15%10Y CAGR +0.42%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q1 FY27
Date3 Nov 2026
EPS estimate$0.4515
Revenue estimate$309.61M
Last reported
Date—
EPS——
Revenue——